Dynamics of dendritic cell migration and the subsequent induction of protective immunity in the lung after repeated airway challenges by nontypeable Haemophilus influenzae outer membrane protein

Vaccine

Volumn 24, Issue 31-32, 2006, Pages 5896-5903

  Kurita, Shin ichi ^a   Koyama, Jun ^a   Onizuka, Shozaburo ^a   Motomura, Kazushi ^a   Watanabe, Hiroshi ^a   Watanabe, Kiwao ^a   Senba, Masachika ^a   Apicella, Michael A ^d   Murphy, Timothy F ^e   Yoneyama, Horoyuki ^c   Matsushima, Kouji ^c   Nagatake, Tsuyoshi ^a   Oishi, Kazunori ^a,b  

^a NAGASAKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

Dendritic cell; Nontypeable Haemophilus influenzae; P6 protein

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN A; OUTER MEMBRANE PROTEIN;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HAEMOPHILUS INFLUENZAE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGLOBULIN PRODUCTION; INFLUENZA; LUNG CLEARANCE; LUNG INFECTION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RECURRENT INFECTION; T LYMPHOCYTE;

EID: 33745663991     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.041     Document Type: Article

References (28)

1. Sethi S., and Murphy T.F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of the art review. Clin Microbiol Rev 14 (2001) 336-363
2. Murphy T.F. Bacterial otitis media: pathogenic considerations. Pediatric Infect Dis J 19 (2000) S9-S16
3. Ubukata. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. J Infect Chemother 9 (2003) 285-291
4. Mylnarczyk G., Mlynarczyk A., and Jeljaszewicz J. Epidemiological aspects of antibiotic resistance in respiratory pathogens. Int J Antimicrobial Agents 18 (2001) 497-502
5. Poolman J.T., Bakaletz L., Cripps A., Danoel P.A., Forsgren A., Kyd J., et al. Developing a nontypeable Heamophilus influenzae (NTHi) vaccine. Vaccine 19 (2001) S108-S115
6. Murphy T.F., Nelson M.B., Dudas K.C., Mylotte J., and Apicella M.A. Identification of a specific epitope of Haemophilus influenzae on a 16,600-dalton outer membrane protein. J Infect Dis 152 (1985) 1300-1307
7. Murphy T.F., Bartos L.C., Campagnari A.A., Nelson M.B., and Apicella M.A. Antigenic characterization of the P6 protein of nontypeable Haemophilus influenzae. Infect Immun 54 (1986) 774-779
8. Bertot G.M., Becker P.D., Guzman C.A., and Grinstein S. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Heamophilus influenzae. J Infect Dis 189 (2004) 1304-1312
9. Sabirov A., Kodama S., Hirano T., Suzuki M., and Mogi G. Intranasal immunization enhances clearance of nontypeable Heamophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect Immun 69 (2001) 2964-2971
10. Kodama S., Suenaga S., Hirano T., Suzuki M., and Mogi G. Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by immunization. Infect Immun 68 (2000) 2294-2300
11. Badr W.H., Loghmanee D., Karalus R.J., Murphy T.F., and Thanavala Y. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses. Vaccine 18 (2000) 29-37
12. Hotomi M., Saito T., and Yamanaka N. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Heamophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin. Vaccine 16 (1998) 1950-1956
13. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
14. Reis e Sousa C., Sher A., and Kaye P. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr Opin Immunol 11 (1999) 392-399
15. Cella M., Engering A., Pinet V., Pietes J., and Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388 (1997) 782-787
16. Itakura M., Tokuda A., Kimura H., Nagai S., Yoneyama H., Onai N., et al. Blockade of secondary lymphoid tissue chemokine exacerbates Propionibacterium acnes-induced acute lung inflammation. J Immunol 166 (2001) 2071-2079
17. McWilliam A.S., Nelson D., Thomas J.A., and Holt P.G. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 179 (1994) 1331-1336
18. Chan V.W.F., Kothakota S., Rochan M.C., Panganiban-Lustan L., Gradner J.P., Wachowicz M.S., et al. Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood 93 (1999) 3610-3616
19. Yanagihara S., Komura E., Nagafune J., Watarai H., and Yanagihara Y. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol (1998) 3096-3102
20. Yoshida R., Nagira M., Imai T., Baba M., Takagi S., Tabira Y., et al. EBL1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cell strongly up-regulate CCR7 and efficiently migrate toward ELC. Int Immunol 10 (1998) 901-910
21. Satoh S., Oishi K., Iwagaki A., Senba M., Akaike A., Akiyama M., et al. Dexamethasone impairs pulmonary defense against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice. Clin Exp Immunol 126 (2001) 266-273
22. Jhonson K.G., McDonald I.J., and Perry M.B. Studies on the cellular and free lipopolisaccharides from Branhamella catarrhalis. Can J Microbiol 22 (1976) 460-467
23. Kurono Y., Yamamoto M., Fujihashi K., Kodama S., Suzuki M., Mogi G., et al. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J Infect Dis 180 (1999) 122-132
24. Fujihashi K., McGhee J.R., Beagley K.W., McPherson D.T., McPherson S.A., Huang C.-H., et al. Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4 and IL-6 producing cells. J Immunol Method 160 (1993) 181-189
25. Greenberger M.J., Strieter R.M., Kunkel S.L., Danforth J.M., Goodman R.E., and Standiford T.J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155 (1995) 722-729
26. Taylor D.C., Cripps W.A., and Clancy R.L. Inhibition of adhesion oh Haemophilus influenzae to buccal cells by respiratory secretions. Immunol Cell Biol 68 (1990) 335-342
27. Kurono Y., Shimamura K., Shigemi H., and Mogi G. Inhibition of bacterial adherence by nasopharyngeal secretions. Ann Otol Rhinol Laryngol 100 (1991) 455-458
28. Abe Y., Murphy T.F., Sethi S., Faden H.S., Dmochowski J., Harabuchi Y., et al. Lymphocyte proliferative response to P6 of Heamophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 165 (2002) 967-971